safety of glp 1 receptor agonists Understanding GLP-1 and their impact on drug discovery GLP-1 Safety Warnings: What to
Description
AT has received honoraria from Boehringer Ingelheim Japan, Mochida, and Amgen
GLP-1 RAs are recommended in the treatment guidelines by the American Diabetes Association as well as the American Association of Clinical Endocrinology (AACE) Consensus Statement & European Society of Cardiology for type 2 diabetes mellitus patients with co-morbidities, like established atherosclerotic cardiovascular disease and obesity
GLP-1 receptor agonists were originally developed to treat T2DM and obesity
This tubuloglomerular feedback mechanism is crucial for preserving renal blood flow and preventing kidney injury
